Publikation
Safety Profile of Upadacitinib up to 3 Years in Psoriatic Arthritis: An Integrated Analysis of Two Pivotal Phase 3 Trials
Wissenschaftlicher Artikel/Review - 30.12.2021
Burmester Gerd R, Liu John, Mccaskill Reva M, Lertratanakul Apinya, Lippe Ralph, Lesser Elizabeth, Rubbert-Roth Andrea, Salvarani Carlo, Azevedo Valderilio F, Goupille Philippe, Nash Peter, Blanco Ricardo, Winthrop Kevin, Ruderman Eric M